Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Urologic Diseases

Phase 1

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

CompletedNCT02052713

GlaxoSmithKlineUrologic Diseases

Start: 2014-02-19End: 2014-12-29Updated: 2018-09-13

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

CompletedNCT02058576

GlaxoSmithKlineUrologic Diseases

Start: 2014-02-11End: 2015-01-02Updated: 2018-09-13